Stryker Corporation (SYK) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SYK Revenue Growth
Revenue Breakdown (FY 2025)
SYK's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
SYK Revenue Analysis (2014–2025)
As of May 6, 2026, Stryker Corporation (SYK) generated trailing twelve-month (TTM) revenue of $25.12 billion, reflecting strong growth of +11.4% year-over-year. The most recent quarter (Q4 2025) recorded $7.17 billion in revenue, up 18.4% sequentially.
Looking at the longer-term picture, SYK's 5-year compound annual growth rate (CAGR) stands at +11.8%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $25.12 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows SYK's business is primarily driven by MedSurg (62%), and Orthopaedics (38%). With over half of revenue concentrated in MedSurg, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ZBH (+9.2% YoY), BSX (+19.9% YoY), and EW (+11.2% YoY), SYK has underperformed the peer group in terms of revenue growth. Compare SYK vs ZBH →
SYK Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SYKCurrent | $25.1B | +11.4% | +11.8% | 19.5% | |
 ZBH | $8.2B | +9.2% | +6.1% | 16.5% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% | |
 EW | $6.1B | +11.2% | +6.7% | 27.0% | |
 BDX | $21.8B | +6.2% | +6.3% | 11.8% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% |
SYK Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $25.12B | +11.2% | $16.07B | 64.0% | $4.89B | 19.5% |
| 2024 | $22.59B | +10.2% | $13.98B | 61.9% | $5.06B | 22.4% |
| 2023 | $20.50B | +11.1% | $12.49B | 61.0% | $4.28B | 20.9% |
| 2022 | $18.45B | +7.8% | $11.04B | 59.8% | $3.73B | 20.2% |
| 2021 | $17.11B | +19.2% | $10.71B | 62.6% | $3.76B | 22.0% |
| 2020 | $14.35B | -3.6% | $8.75B | 61.0% | $3.03B | 21.1% |
| 2019 | $14.88B | +9.4% | $9.38B | 63.0% | $3.39B | 22.8% |
| 2018 | $13.60B | +9.3% | $8.60B | 63.2% | $3.10B | 22.8% |
| 2017 | $12.44B | +9.9% | $7.90B | 63.5% | $2.77B | 22.2% |
| 2016 | $11.32B | +13.9% | $7.25B | 64.0% | $2.58B | 22.8% |
Full SYK Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See SYK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SYK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SYK vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSYK — Frequently Asked Questions
Quick answers to the most common questions about buying SYK stock.
Is SYK's revenue growth accelerating or slowing?
SYK maintains +11.4% revenue growth, in line with its 5-year CAGR of +11.8%. TTM revenue stands at $25.1B. Growth rate remains consistent with historical average.
What is SYK's long-term revenue growth rate?
Stryker Corporation's 5-year revenue CAGR of +11.8% reflects the sustained expansion pattern. Current YoY growth of +11.4% is near this long-term average.
How is SYK's revenue distributed by segment?
SYK reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.